{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T01:40:13Z","timestamp":1742780413620,"version":"3.40.2"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,23]]},"DOI":"10.7759\/cureus.81047","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T01:17:17Z","timestamp":1742779037000},"source":"Crossref","is-referenced-by-count":0,"title":["Recurrent Acquired Angioedema as a Heralding Sign of Splenic Marginal Zone Lymphoma Recurrence"],"prefix":"10.7759","author":[{"given":"Taxiarhia J","family":"Arabatzis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandrakala J","family":"Dadeboyina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haleigh J","family":"Minor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong Mary","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prianka","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2022.08.003","article-title":"Isolated angioedema: a review of classification and update on management","volume":"129","author":"Kesh S","year":"2022","unstructured":"Kesh S, Bernstein JA. Isolated angioedema: a review of classification and update on management. Ann Allergy Asthma Immunol. 2022, 129:692-702. 10.1016\/j.anai.2022.08.003","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2019.07.035","article-title":"Angioedema as a systemic disease","volume":"37","author":"Kazandjieva J","year":"2019","unstructured":"Kazandjieva J, Christoff G. Angioedema as a systemic disease. Clin Dermatol. 2019, 37:636-43. 10.1016\/j.clindermatol.2019.07.035","journal-title":"Clin Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/hon.3152","article-title":"Marginal zone lymphomas","volume":"41 Suppl 1","author":"Zucca E","year":"2023","unstructured":"Zucca E, Rossi D, Bertoni F. Marginal zone lymphomas. Hematol Oncol. 2023, 41 Suppl 1:88-91. 10.1002\/hon.3152","journal-title":"Hematol Oncol"},{"key":"ref4","article-title":"Acquired angioedema","author":"Swanson TJ","year":"2025","unstructured":"Swanson TJ, Bhupendra, Patel C. Acquired angioedema. StatPearls [Internet]. StatPearls Publishing, Treasure Island; 2025 Jan-."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13908","article-title":"High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibitor deficiency","volume":"172","author":"Castelli R","year":"2016","unstructured":"Castelli R, Wu MA, Arquati M, Zanichelli A, Suffritti C, Rossi D, Cicardi M. High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibitor deficiency. Br J Haematol. 2016, 172:902-8. 10.1111\/bjh.13908","journal-title":"Br J Haematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2016.09.005","article-title":"Splenic marginal zone lymphoma","volume":"30","author":"Piris MA","year":"2017","unstructured":"Piris MA, Onaind\u00eda A, Mollejo M. Splenic marginal zone lymphoma. Best Pract Res Clin Haematol. 2017, 30:56-64. 10.1016\/j.beha.2016.09.005","journal-title":"Best Pract Res Clin Haematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-018-1183-7","article-title":"Splenic marginal zone lymphomas in acquired C1-inhibitor deficiency: clinical and molecular characterization","volume":"35","author":"Sbattella M","year":"2018","unstructured":"Sbattella M, Zanichelli A, Ghia P, et al.. Splenic marginal zone lymphomas in acquired C1-inhibitor deficiency: clinical and molecular characterization. Med Oncol. 2018, 35:118. 10.1007\/s12032-018-1183-7","journal-title":"Med Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.glmedi.2024.100118","article-title":"An autopsy presentation of spontaneous splenic rupture in chronic myeloid leukemia: a rare case report","volume":"3","author":"Kanani J","year":"2024","unstructured":"Kanani J, Sheikh MI,. An autopsy presentation of spontaneous splenic rupture in chronic myeloid leukemia: a rare case report. J Med Surg Pub Health. 2024, 3:100118. 10.1016\/j.glmedi.2024.100118","journal-title":"J Med Surg Pub Health"},{"key":"ref9","unstructured":"NCC Guidelines. B Cell Lymphomas. (2025). Accessed: 02\/21\/2025: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1480."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjhh.2016.09.014","article-title":"Splenic marginal zone lymphoma: a literature review of diagnostic and therapeutic challenges","volume":"39","author":"Santos TS","year":"2017","unstructured":"Santos TS, Tavares RS, Farias DL. Splenic marginal zone lymphoma: a literature review of diagnostic and therapeutic challenges. Rev Bras Hematol Hemoter. 2017, 39:146-54. 10.1016\/j.bjhh.2016.09.014","journal-title":"Rev Bras Hematol Hemoter"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-11-624312","article-title":"Splenic marginal zone lymphoma: from genetics to management","volume":"127","author":"Arcaini L","year":"2016","unstructured":"Arcaini L, Rossi D, Paulli M. Splenic marginal zone lymphoma: from genetics to management. Blood. 2016, 127:2072-81. 10.1182\/blood-2015-11-624312","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol28060430","article-title":"CD5-negative, CD10-negative low-grade B-cell lymphoproliferative disorders of the spleen","volume":"28","author":"Schmieg JJ","year":"2021","unstructured":"Schmieg JJ, Muir JM, Aguilera NS, Auerbach A. CD5-negative, CD10-negative low-grade B-cell lymphoproliferative disorders of the spleen. Curr Oncol. 2021, 28:5124-47. 10.3390\/curroncol28060430","journal-title":"Curr Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13667","article-title":"Acquired angioedema in B cell lymphoproliferative disease: a retrospective case series","volume":"206","author":"Wonnaparhown A","year":"2021","unstructured":"Wonnaparhown A, Stefanovic A, Lugar P, Hostetler HP. Acquired angioedema in B cell lymphoproliferative disease: a retrospective case series. Clin Exp Immunol. 2021, 206:378-83. 10.1111\/cei.13667","journal-title":"Clin Exp Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004363","article-title":"A nationwide study of acquired C1-inhibitor deficiency in France: characteristics and treatment responses in 92 patients","volume":"95","author":"Gobert D","year":"2016","unstructured":"Gobert D, Paule R, Ponard D, et al.. A nationwide study of acquired C1-inhibitor deficiency in France: characteristics and treatment responses in 92 patients. Medicine (Baltimore). 2016, 95:e4363. 10.1097\/MD.0000000000004363","journal-title":"Medicine (Baltimore)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1159\/000509805","article-title":"Acquired angioedema due to C1 inhibitor deficiency preceding splenic marginal zone lymphoma: further insights from clinical practice","volume":"181","author":"Ferriani MP","year":"2020","unstructured":"Ferriani MP, Trevisan-Neto O, Costa JS, et al.. Acquired angioedema due to C1 inhibitor deficiency preceding splenic marginal zone lymphoma: further insights from clinical practice. Int Arch Allergy Immunol. 2020, 181:941-6. 10.1159\/000509805","journal-title":"Int Arch Allergy Immunol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2013.02.004","article-title":"Acquired C1-inhibitor deficiency and lymphoproliferative disorders: a tight relationship","volume":"87","author":"Castelli R","year":"2013","unstructured":"Castelli R, Zanichelli A, Cicardi M, Cugno M. Acquired C1-inhibitor deficiency and lymphoproliferative disorders: a tight relationship. Crit Rev Oncol Hematol. 2013, 87:323-32. 10.1016\/j.critrevonc.2013.02.004","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/344861-recurrent-acquired-angioedema-as-a-heralding-sign-of-splenic-marginal-zone-lymphoma-recurrence","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T01:17:26Z","timestamp":1742779046000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/344861-recurrent-acquired-angioedema-as-a-heralding-sign-of-splenic-marginal-zone-lymphoma-recurrence"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,23]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.81047","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,23]]}}}